Rare blood group antibody linked to severe HDFN in newborn
A case of HDFN caused by anti-Jkb antibody highlights the need for detailed blood tests in infants with unexplained jaundice.
A case of HDFN caused by anti-Jkb antibody highlights the need for detailed blood tests in infants with unexplained jaundice.
Learn more about when a baby receives the most maternal antibodies during pregnancy and how the antibodies are transferred to the fetus.
Despite advances in screening and treatment, HDFN remains a significant cause of perinatal morbidity and mortality worldwide.
A newly found blood variant common in Indigenous Australians may raise HDFN risk by triggering anti-D antibodies.
A pediatric hematologist has the expertise to help manage both immediate and long-term complications of HDFN.
A study showed children with HDFN needed more hospital care in their first year of life compared with those without the condition.
Learn more about how the risk of HDFN in subsequent pregnancies is affected if the infants have different fathers.
The patient was found to have a partial D variant called DBT that is difficult to detect with standard serologic testing.
Deciding when to stop IUTs requires balancing the risks of continuing the treatment versus the risks of delivering a premature baby.
A new case study emphasizes the importance of accurately identifying rare blood antibodies in pregnancy for the management of HDFN.